This result represents the first evidence that cells knocked down for PC1 expressing an endogenous functional CaSR, respond to the calcimimetic NPS-R568 with a significant reduction in cAMP intracellular levels, thus attenuating one of the pivotal dysregulations characterizing ADPKD. The gene discussed is PKD1; the disease is autosomal dominant polycystic kidney disease.